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Subclavian artery transposition and bypass
techniques for use with endoluminal repair
of acute and chronic thoracic aortic pathology
Mark D. Morasch, MD, and Brian Peterson, MD, Chicago, IllSignificant proportions of patients with both acute and
chronic thoracic aortic pathology are found to have disease
adjacent to the origin of the great vessels. Although open
surgical repair remains the best treatment option for some,
management often requires hypothermic circulatory arrest
to safely complete the proximal anastomosis.When patients
are considered for endoluminal therapy, several different
treatment paradigms have been developed for managing
proximal thoracic aortic pathology.1,2 When pathology
abuts the left subclavian artery, some advocate the extra-
anatomic rerouting of cerebrovascular and upper extremity
blood flow with subclavian-carotid transposition or by-
pass.3-7 Others advocate simply ignoring the left subclavian
artery, and they deploy the covered or the bare-wire por-
tions of the stent-graft device over the origin of the subcla-
vian artery.8-15 Branched endografts are currently being
developed. Techniques to fenestrate the endograft material
and deploy stents through the device have also been
used.16-18 There is clearly no consensus on how best to
handle the great vessels in patients with proximal thoracic
aortic disease. Most do agree that the status of the vertebral
circulation is an important factor in choosing a treatment
path.
TECHNIQUE
The subclavian artery may be transposed to or bypassed
from the adjacent carotid artery. Not only is preservation of
the vertebral artery critical, but it is equally important to
mobilize and preserve the valuable internal mammary artery
when performing a subclavian transposition. Arterial trans-
positions are completed through a short, transverse cervical
incision above the clavicle. For a transposition, the surgical
dissection is performed between the two heads of the
sternocleidomastoid muscle. After the omohyoid muscle is
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doi:10.1016/j.jvs.2005.10.060divided, the jugular vein and the vagus nerve are reflected
laterally, and the common carotid is dissected out circum-
ferentially and reflected medially. On the left side, the
thoracic duct is identified, ligated, and divided. Multiple
additional cervical lymphatic channels must also be tied.
After the vertebral vein is divided, the subclavian artery and
its proximal branches are carefully dissected from surround-
ing tissues and must be controlled. The subclavian artery as
it passes from the thoracic outlet is particularly thin walled,
with a consistency much like the pulmonary artery. Care
must be taken when manipulating this vessel. Caution
should also be exercised when isolating and controlling the
vertebral artery, because it takes origin from an awkward
position on the posterior aspect of the subclavian. Once
heparin has been administered, the subclavian is transected
over a right-angled clamp, as far proximal as possible,
behind the clavicle. It is important to secure the proximal
stump immediately after the artery has been divided; if
control of the transected stump is lost in the chest or
mediastinum, the consequences clearly can be devastating.
After the carotid is rotated a quarter turn counterclockwise
to expose its posterior aspect, a punch arteriotomy is cre-
ated on this donor vessel, and the end-to-side subclavian-
to-carotid anastomosis is completed without tension by
using fine monofilament suture (Fig 1).
Occasionally, it is not feasible to perform a straightfor-
ward arterial transposition, so a bypass conduit becomes
necessary. Arterial transposition is not possible when the
vertebral artery takes off early from the subclavian artery.
Patients with a functioning coronary revascularization
using an internal mammary artery should also undergo a
bypass rather than a transposition to preserve myocardial
perfusion during the procedure by means of sequential
clamping distal to the internal mammary artery. Bypasses
are performed most expediently through dissection just
lateral to the clavicular head of the sternocleidomastoid
muscle. The jugular vein is reflected medially to expose the
common carotid. The subclavian artery is identified more
distally than during transposition by dividing the anterior
scalene muscle. The bypass is completed into the ret-
roscalene portion of the subclavian artery, usually with a
prosthetic conduit rather than a vein, by performing se-
quential clamping and serial anastomoses.
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dograft is necessary and an extra-anatomic approach is
considered, the only source vessel will be found on the
opposite side of the neck. If this extra-anatomic approach is
used, the midline should be crossed by using a retropha-
ryngeal rather than a presternal or pretracheal path. The
retropharyngeal route is shorter and more direct. Further-
more, pretracheal or presternal routing of a bypass graft can
result in erosion of the overlying skin and will be found
obtrusive if the patient ever requires a sternotomy or a
tracheotomy. Long subclavian-subclavian, axillary-axillary,
and femoro-axillary bypasses should also be avoided unless
there is no other alternative.
Complete debranching of the aortic arch is performed
through a median sternotomy. A prosthetic graft, used to
reroute the extra-anatomic circulation, usually takes origin
from the ascending aorta. Before heparin is administered, a
side-biting clamp is applied, and the proximal anastomosis
is performed end to side to a soft spot on the anterolateral
aspect of the aorta distal to the aortic valve. Side branches
are attached as needed to reperfuse all the great vessels.
LOCAL EXPERIENCE
The proximal extent of the aortic pathology was adja-
cent to the great vessels in 28 (40%) of the 70 patients
treated at Northwestern Memorial Hospital. The left sub-
Fig 1. Completed subclavian-to-carotid transposition.clavian artery was managed by transposition into the leftcommon carotid before the endograft deployment in 19
cases (Fig 2). This included two patients with aberrant right
subclavian vessels, who had both the right and left subcla-
vian vessels transposed at separate settings before surgery.
One patient with a functioning left internal mammary
coronary bypass had a prosthetic carotid-to-subclavian by-
pass immediately before repair of a leaking thoracic aneu-
rysm. Another had a bypass to the subclavian artery from a
reconstructed aortic arch. The arch reconstruction and
subclavian bypass were performed under hypothermic cir-
culatory arrest, and to treat descending aortic pathology, an
endograft was then deployed that covered the subclavian
origin. Finally, one patient required subclavian artery-to-
common carotid artery transposition after later developing
left upper extremity and posterior circulation symptoms
following thoracic endograft placement. The remaining six
patients had a nontransposed subclavian origin covered by
the proximal end of the covered portion of the stent graft.
Five complications occurred in the six patients who had
the subclavian origin covered without revascularization.
Four of them experienced strokes. Three of these had
Fig 2. Endograft deployed to the origin of the bovine innomi-
nate. Note the patent transposition and dominant vertebral artery.magnetic resonance imaging–confirmed posterior circula-
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distribution of the posterior circulation, ipsilateral to the
covered subclavian artery. Upon further review of available
imaging, in both cases the contralateral vertebral was hyp-
oplastic or absent. One patient, mentioned previously,
developed symptoms of subclavian-vertebral steal, includ-
ing arm fatigue/pain and syncope, shortly after endograft
placement and left subclavian coverage. This patient re-
quired subclavian revascularization via subclavian-to-
carotid transposition 7 months after the endograft proce-
dure for treatment of persistent posterior circulation
symptoms.
Among the 22 patients who underwent subclavian
reconstruction before or after endograft placement, 2 com-
plications were directly related to this procedure. Two
patients experienced left-sided vocal cord palsy, presumably
related to traction on the vagus or the recurrent nerve. The
paralyzed vocal cords were confirmed 1 month after the
procedure by indirect laryngoscopy. Both patients had
clinical resolution of their symptoms 3 months later after
undergoing cord injection with silicone. Another patient
from this group experienced delayed spinal cord ischemia
and bilateral lower extremity paresis after endograft place-
ment. There were no strokes or procedure-related deaths in
this group. All subclavian-to-carotid artery transpositions
have remained patent at a mean follow-up of 18 months
(range, 1-51months), and there has been no late morbidity
related to the transposition procedure.
DISCUSSION
Although various types of pathology may abut the left
subclavian artery, some disease processes—namely, trau-
matic transection and dissection—generally occur within
close proximity to the origin of the great vessels. This
occurrence underscores the importance of being able to
Literature summary
Study Proximal aortic cases Subclavian cov
Mitchell23 13 2 
Grabenwoger7 9 0 
Moore14 1 0 
Hausegger9 6 4 
Cambria12 6 0 
Criado1 13 5 
Criado2 9 2 
Gorich8 22 21 
Heijmen6 5 0 
Burks15 3 1 
Tiesenhausen10 10 8 
Lambrechts13 7 6 
Hutton24 1 1 
Hansen25 4 4 
Leurs26 79 42 
Northwestern 30 8
Total 218 104
Nuero, Nuerological; UE, upper extremity; VC, vocal cord.position endoluminal devices high in the descending tho-racic aorta, even with extension into the aortic arch, if we
are to treat these lesions by endovascular means. In our
experience, 40% of patients who underwent endovascular
repair of acute or chronic thoracic aortic pathology had
lesions that were adjacent to or involved the origin of the
great vessels.
Previously published series have addressed the topic of
proximal thoracic aortic pathology, but no consensus on
how best to treat these patients has arisen. The initial Gore
Thoracic Excluder endograft trial design required pretreat-
ment subclavian relocation or bypass for proximal aneu-
rysms to minimize ischemic complications or continued sac
perfusion. Other device trials have left this important deci-
sion up to the discretion of the operator.
Some groups have sought to lengthen the proximal land-
ing zones via carotid-to-carotid and carotid-to-subclavian
artery bypass.3-7 Although these bypass procedures may ad-
dress the issue of lengthening the proximal neck to ensure an
adequate seal length, they generate the potential for type II
endoleak. Furthermore, bypass allows for continued perfusion
of the sac in the setting of aneurysmal disease or of the false
lumen in the case of dissection.
Some groups have demonstrated success by using tech-
niques designed to maintain normal great vessel perfusion
with scallop-edged or bare metal– ended stent grafts.14,15,18,19
Alternatively, some have used stent-graft fenestration and
retrograde stent deployment through the device and into
the arch branch. Branched endovascular prostheses are
presently being developed, but widespread acceptance is
likely years away.16,17 Large series and long-term follow-up
are lacking.
Perhaps the added complexity of great vessel manage-
ment is unnecessary and coverage of the great vessel ori-
gins, at least the left subclavian, can be routinely performed
with impunity. Indeed, some groups have suggested that
Subclavian transposed Outcome
11 1 neuro
9 No complications
1 No complications
2 No complications
6 No complications
8 1 lymphatic (transposition)
7 No complications
1 4 endoleaks, 4 neuro, 2 UE,
1 spinal
5 No complications
2 No complications
2 2 endoleaks, 3 neuro
1 No complications
0 1 neuro
0 No complications
37 1 neuro
22 4 neuro, 1 UE, 2 VC palsy
(transposition)
114 Complications: 23% vs 3%eredcoverage of the left subclavian artery is well tolerated and
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served for patients who subsequently develop symptoms
that necessitate intervention.8-15 A recent literature sum-
mary (Table) would suggest that subclavian coverage may
not be so benign. Complications arising directly from sub-
clavian coverage occurred in 23% of patients, whereas sim-
ilar complications did not occur in the patients who had
subclavian perfusion maintained.20 Our cohort of patients
had similar complications after subclavian coverage. In fact,
four of six patients who underwent coverage of the subcla-
vian origin in our series developed strokes in the immediate
postoperative period. Although we cannot state with cer-
tainty that these would have been prevented by antecedent
transposition and one could certainly argue that proximal
disease is simply a marker for increased stroke risk overall,
the findings of isolated posterior circulation events in two
of our patients with absent or hypoplastic contralateral
vertebral arteries certainly would suggest that ipsilateral
vertebral perfusion remains critical. The fifth patient who
required late subclavian revascularization for persistent pos-
terior circulation symptoms also adds credence to this
viewpoint.
Although perhaps not necessary in every case, transpo-
sition of the subclavian to the carotid artery has many
inherent advantages over great vessel coverage. The advan-
tages of maintaining adequate perfusion to the left upper
extremity and to the ipsilateral vertebral artery via the left
subclavian artery are obvious. Additionally, spinal cord
perfusion is optimized by preserving important collateral
perfusion via the vertebral artery and its anterior spinal
branch. As mentioned previously, the potential for a type II
endoleak or continued perfusion of a dissected false lumen
from retrograde subclavian blood flow is eliminated after a
transposition procedure. The risks associated with subcla-
vian transposition in experienced hands are few.21,22 The
procedure was well tolerated in the 22 patients in this series
who underwent subclavian-to-carotid artery transposition.
The two patients who developed left-sided vocal cord pal-
sies had resolution of symptoms within a matter of months
without residual morbidity. In addition to the present series,
which demonstrated 100% patency rates at 18 months of
follow-up, the safety, efficacy, and durability of subclavian-to-
carotid transposition are well known.21,22
Despite the relative ease and lowmorbidity of bypass or
transposition, perhaps we should be selective. Besides risk
to the recurrent and vagus nerves, other complications,
including bleeding, thoracic duct leak, lymphocele, and
Horner syndrome, can also follow transposition. Although
many alternative paradigms exist, we choose to perform
transposition procedures when situations necessitate the
rerouting of the arch vessels for the aforementioned rea-
sons. We would argue that, in instances when thoracic
aortic pathology arises within 15 mm of the origin of the
most distal great vessel, prophylactic subclavian-to-carotid
artery transposition or bypass is warranted when the dom-
inant vertebral artery arises ipsilaterally. In elective circum-
stances and when time permits, we choose to perform
preoperative imaging of the extracranial cerebrovasculatureby usingmagnetic resonance angiography to fully assess the
status of the vertebrobasilar system before deciding to
transpose or cover. In situations when urgent or emergent
endovascular reconstruction is necessary (as in traumatic
aortic transection), we make every effort to image these
same vessels, at least proximally, with catheter-based an-
giography before deploying the device. When patients
present with extensive descending thoracic pathology and
coverage of multiple intercostal vessels is necessary, a trans-
position procedure to maintain optimal spinal cord perfu-
sion may be useful. Patients with very proximal aneurysms
and those with descending thoracic dissections with a pro-
hibitive risk for open repair require definitive management
of the great vessels to avoid retrograde flow into the aneu-
rysm sac or into the dissected false lumen. Finally, it is
important to remember that patients with previous coro-
nary revascularization using the left internal mammary as a
bypass conduit require carotid-to-subclavian bypass if the
origin of the subclavian is to be sacrificed.
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